AstraZeneca shares are trading higher as the stock rebounds after falling Monday on lung cancer.trial results.
Portfolio Pulse from Benzinga Newsdesk
AstraZeneca's stock is trading higher after a drop on Monday due to lung cancer trial results.
July 05, 2023 | 3:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AstraZeneca's shares are recovering after a drop due to lung cancer trial results.
The news directly mentions AstraZeneca and its stock price. The company's shares are trading higher after a drop on Monday due to lung cancer trial results. This indicates a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100